(Q44397764)

2 December 2017

title

Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa (English)

1 reference

2 December 2017

2

Robert Flisiak

1 reference

Alicja Wiercińska-Drapało

2 December 2017

series ordinal

1

object named as

Alicja Wiercińska-Drapało

1 reference

2 December 2017

Danuta Prokopowicz

3

1 reference

2 December 2017

publication date

1 May 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

113

1 reference

2 December 2017

issue

1-3

1 reference

2 December 2017

page(s)

57-61

1 reference

Inflammatory bowel disease: etiology and pathogenesis

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Transforming growth factor beta signaling mediators and modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Role of transforming growth factor beta in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

1 reference

7 January 2021

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Stimulation of transforming growth factor β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Cutaneous wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

TGF-beta in blood: a complex problem

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Serum transforming growth factor-beta1 levels increase in response to successful anti-inflammatory therapy in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

Transforming growth factor-beta messenger RNA and protein in murine colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900300-2

7 January 2021

10.1016/S0167-0115(02)00300-2

Identifiers

DOI

1 reference

2 December 2017

1 reference